Mitigating Cardiovascular Dysfunction Across the Cancer Continuum

Nonniekaye M. Shelburne

Marilyn J. Hammer
cardiovascular disease, heart failure, cancer
ONF 2018, 45(1), 15-17. DOI: 10.1188/18.ONF.15-17

The mechanisms and outcomes of cancer treatment–related cardiovascular dysfunction are complex and influenced by cardiotoxic treatment exposure, preexisting heart disease, and lifestyle factors. Establishing and implementing evidence to prevent, detect, and manage cancer treatment–related cardiotoxicity requires engagement by the nursing science community.

Members Only
Not a current ONS member or journal subscriber?

Purchase This Article

Receive a PDF to download and print.